Open Field Test Sample Clauses

Open Field Test. Mice were handled once per day for two days prior to testing. The open field consisted of an open box (27.9 cm x 27.9 cm) made of PLEXIGLAS. Subjects were placed in the apparatus to explore for 10 minutes, and then returned to their home cage. All testing was conducted under standard room lighting. Activity data was analyzed using the Open Field Activity Software (Med Associates Inc., St. Albans, VT) for locomotor activity and anxiety-like behavior.
AutoNDA by SimpleDocs
Open Field Test. Subjects were handled once per day for two days prior to testing. The open field consisted of an open box (27.9 cm x 27.9 cm) made of PLEXIGLAS. Subjects were placed in the apparatus to explore for 10 minutes, and then returned to their home cage. All testing was conducted under standard room lighting. Activity data was analyzed using the Open Field Activity Software (Med Associates Inc., St. Albans, VT) for locomotor activity (distance traveled in cm over 10 minutes) and anxiety-like behavior (time spent in center of chamber in sec, where center is defined as 6 cm from the perimeter of chamber walls).

Related to Open Field Test

  • Field Trips Orange COUNTY funds may not be used to support any overnight and/or out of Central Florida travel, unless approved by the COUNTY’S Manager of the CCC or designee in advance. The AGENCY must have on file for field trip(s) that each participant, adult or minor, must have a signed release of liability form releasing the COUNTY from any liability. If the participant is a minor, the release must be signed by a parent/guardian. Central Florida is defined as Orange, Osceola, Seminole, Brevard, Lake, Polk, and Volusia Counties.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Drug Test Results 1. All records pertaining to department-required drug tests shall remain confidential, and shall not be provided to other employers or agencies without the written permission of the person whose records are sought. However, medical, administrative, and immediate supervisory personnel may have access to relevant portions of the records as necessary to insure the acceptable performance of the officer's job duties.

  • Drug Test The compulsory production and submission of urine and/or blood, in accordance with departmental procedures, by an employee for chemical analysis to detect prohibited drug usage.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

Time is Money Join Law Insider Premium to draft better contracts faster.